News Orders & Deals Mirae Asset Mutual Fund Increases Stake in Laurus Labs to 4.03% Through Open Market PurchaseMirae Asset Mutual Fund Increases Stake in Laurus Labs to 4.03% Through Open Market Purchase
Mirae Asset Investment Managers (India) Private Limited has increased its stake in Laurus Labs Limited through the acquisition of 111,064 shares via open market transactions on February 18, 2026. The purchase raised the mutual fund's holding from 4.01% to 4.03% of the total share capital, representing 21,737,464 shares. The disclosure was filed under SEBI regulations on February 19, 2026, confirming compliance with substantial acquisition norms for the pharmaceutical company listed on NSE and BSE.
*this image is generated using AI for illustrative purposes only.
Mirae Asset Investment Managers (India) Private Limited has disclosed a substantial acquisition of shares in Laurus Labs Limited, filing the mandatory disclosure under SEBI regulations on February 19, 2026. The acquisition represents a strategic increase in the mutual fund's stake in the pharmaceutical company through open market transactions.
Transaction Details
The mutual fund acquired 111,064 shares of Laurus Labs through open market purchases on February 18, 2026. This acquisition increased Mirae Asset Mutual Fund's total shareholding in the company from 21,626,400 shares to 21,737,464 shares.
| Parameter: | Before Acquisition | After Acquisition |
|---|---|---|
| Number of Shares: | 21,626,400 | 21,737,464 |
| Percentage of Total Share Capital: | 4.01% | 4.03% |
| Percentage of Diluted Share Capital: | 4.00% | 4.02% |
Shareholding Structure
The acquisition details reveal the fund's position relative to Laurus Labs' overall capital structure:
| Capital Structure: | Details |
|---|---|
| Equity Share Capital: | 539,856,582 shares |
| Total Diluted Share Capital: | 541,032,426 shares |
| Shares Acquired: | 111,064 |
| Acquisition Method: | Open Market |
Regulatory Compliance
The disclosure was made in accordance with Regulation 29(2) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. Mirae Asset Investment Managers confirmed that the acquirer does not belong to the promoter or promoter group of Laurus Labs Limited.
The filing was signed by Rimmi Jain, Head of Compliance, Legal and Company Secretary at Mirae Asset Investment Managers (India) Private Limited, and submitted to both the National Stock Exchange of India Ltd. and BSE Ltd., where Laurus Labs shares are listed.
Market Context
Laurus Labs Limited trades on both major Indian stock exchanges with NSE symbol LAURUSLABS and BSE script code 540222. The company's shares carry the ISIN INE947Q01028. The acquisition represents a marginal but notable increase in institutional holding, reflecting continued investor interest in the pharmaceutical sector.
The transaction maintains Mirae Asset Mutual Fund's position as a significant institutional investor in Laurus Labs, with the increased stake demonstrating confidence in the company's prospects within the pharmaceutical industry.
Historical Stock Returns for Laurus Labs
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -0.22% | +0.04% | -4.11% | +15.28% | +86.37% | +178.91% |
15
